Insider · CIK 0001615979
Koh Bong Y
Reports to the SEC for 11 companies · NEW YORK, NY
Transactions
14
Companies
11
Filings
5
CIK
0001615979
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2018-05-15 | AveXis, Inc.D Disposition to Issuer | — |
| 2018-05-15 | AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2018-05-15 | AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2018-05-15 | AveXis, Inc.D Disposition to Issuer | — |
| 2018-05-15 | AveXis, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2018-03-13 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
| 2018-03-13 | AveXis, Inc.A Award | — |
| 2017-05-30 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-02-17 | AveXis, Inc.C Conversion | — |
| 2016-02-17 | AveXis, Inc.P Purchase | +$2M |
| 2016-02-17 | AveXis, Inc.Class B-1 Common StockC Conversion | — |
| 2016-02-17 | AveXis, Inc.Class D Common StockC Conversion | — |
| 2016-02-10 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-02-10 | AveXis, Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Koh Bong Y0001209191-18-030122SEC(opens sec.gov)
- 4Koh Bong Y0001209191-18-022245SEC(opens sec.gov)
- 4AveXis, Inc.0001209191-17-036894SEC(opens sec.gov)
- 4AveXis, Inc.0001209191-16-100628SEC(opens sec.gov)
- 4AveXis, Inc.0001209191-16-098228SEC(opens sec.gov)
Companies
- Adverum Biotechnologies, Inc.10% Owner
- Altimmune, Inc.10% OwnerALT
- AveXis, Inc.Director
- Bellerophon Therapeutics, Inc.10% Owner
- Cogent Biosciences, Inc.10% OwnerCOGT
- CONSTELLATION PHARMACEUTICALS INC10% Owner
- KalVista Pharmaceuticals, Inc.10% Owner
- Oruka Therapeutics, Inc.10% OwnerORKA
- Shockwave Medical, Inc.10% Owner
- Tricida, Inc.10% Owner
- Vistagen Therapeutics, Inc.10% OwnerVTGN
Address
C/O VENROCK 7 BRYANT PARK, 23RD FLOOR
NEW YORK, NY, 10018